Patents by Inventor Peter Kleber

Peter Kleber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6653112
    Abstract: L(−)-carnitine is synthesized from crotonobetaine, crotonobetaine salts or derivatives in an ecologically advantageous manner by immobilizing cells of Escherichia coli 044 K74 on ceramics, glass beads or polyurethane disks in a two stage continuously operating cell recycle reactor containing a reaction medium. The medium preferably contains between 25 mM and 1 M crotonobetaine and at least 50 mM fumarate. Growing or resting cells of E. coli are retained in the reactor by micro or ultrafiltration membranes which are arranged as a flat membrane module or hollow fiber module. A first stage contains a reactor tank and a second stage contains an external recirculation loop connected to the tank for feeding the reaction medium through a filter unit. L-carnitine is synthesized under anaerobic conditions to produce a reaction medium containing L-carnitine and unreacted crotonobetaine.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: November 25, 2003
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Hans-Peter Kleber, Manuel Canovas-Diaz, Jose Maria Obon, Jose Maria Iborra
  • Patent number: 6562608
    Abstract: The invention described herein relates to coenzymes useful for the synthesis of L-carnitine, particularly a compound of coenzyme A, and more particularly gamma-butyrobetainyl-coenzyme A and crotonobetainyl-coenzyme A, to procedures for their preparation and to their use for the production of L(−)-carnitine from crotonobetain and D(−)-carnitine.
    Type: Grant
    Filed: March 26, 2002
    Date of Patent: May 13, 2003
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Thomas Elssner, Hans-Peter Kleber
  • Publication number: 20030073203
    Abstract: The invention relates to a method for producing L(−)-carnitine. The aim of the invention is to depict a method which permits the synthesis of L(−)carnitine from crotonobetaine. crotonobetaine salts or derivatives in an ecologically advantageous manner by immobilizing cells of Escherichia coli 044 K74 in a continuously operating cell recycle reactor. Growing or resting cells of E. coli are retained in a continuously operating cell recycle reactor by micro or ultrafiltration membranes which are arranged as a flat membrane module or hollow chamfer module.
    Type: Application
    Filed: May 12, 2000
    Publication date: April 17, 2003
    Inventors: HANS-PETER KLEBER, MANUEL CANOVAS-DIAZ, JOSE MARIA OBON, JOSE LUIS IBORRA
  • Publication number: 20020146787
    Abstract: The invention described herein relates to coenzymes useful for the synthesis of L-carnitine, particularly a compound of coenzyme A, and more particularly gamma-butyrobetainyl-coenzyme A and crotonobetainyl-coenzyme A, to procedures for their preparation and to their use for the production of L(−)-carnitine from crotonobetain and D(−)-carnitine.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 10, 2002
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
    Inventors: Thomas Elssner, Hans-Peter Kleber
  • Patent number: 6379936
    Abstract: The invention described herein relates to coenzymes useful for the synthesis of L-carnitine, particularly a compound of coenzyme A, and more particularly gamma-butyrobetainyl-coenzyme A and crotonobetainyl-coenzyme A, to procedures for their preparation and to their use for the production of L(−)-carnitine from crotonobetaine and D(−)-carnitine.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: April 30, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Thomas Elssner, Hans-Peter Kleber
  • Patent number: 6337197
    Abstract: The invention described herein relates to coenzymes useful for the synthesis of L-carnitine, particularly a compound of coenzyme A, and more particularly gamma-butyrobetainyl-coenzyme A and crotonobetainyl-coenzyme A, to procedures for their preparation and to their use for the production of L(−)-carnitine from crotonobetain and D(−)-carnitine.
    Type: Grant
    Filed: April 11, 2001
    Date of Patent: January 8, 2002
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Thomas Elssner, Hans-Peter Kleber
  • Publication number: 20010021521
    Abstract: The invention described herein relates to coenzymes useful for the synthesis of L-carnitine, particularly a compound of coenzyme A, and more particularly gamma-butyrobetainyl-coenzyme A and crotonobetainyl-coenzyme A, to procedures for their preparation and to their use for the production of L(−)-carnitine from crotonobetain and D(−)-carnitine.
    Type: Application
    Filed: April 11, 2001
    Publication date: September 13, 2001
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Thomas Elssner, Hans-Peter Kleber
  • Patent number: 5028538
    Abstract: The invention relates to a process for the L(-)-carnitine biochemical production, in an economically favorable way.This new process is technically achievable with easily available raw, materials in simple reaction conditions and with not complicated substance separation techniques.This process is carried out with bacteria that stereo-specifically hydrates crotonobetaine to L(-)-carnitine.
    Type: Grant
    Filed: May 9, 1989
    Date of Patent: July 2, 1991
    Assignee: Sigma Tau Industries Farmaceutiche Riunite S.p.A.
    Inventors: Hermann Seim, Heniz Loester, Rainer Claus, Hans-Peter Kleber, Erich Strack
  • Patent number: 4906568
    Abstract: An enzyme carnitinehydrolyase is isolated from microorganisms belonging to the family Enterobacteriaceae, particularly Escherichia coli, Proteus vulgarius, Proteus mirabilis, Citrobacter freundii, Salmonella typhimurium, Salmonella anatum, e Salmonella cottbus, following anaerobic cultivation of the microorganisms in the presence of D,L-carnitine and/or crotonobetaine, by cell disruption and chromatography of the resulting protein extract. The enzyme, upon immobilization and activation by an effector which is also obtained from the protein extract following enzyme isolation, is used for stereoselectively hydrating crotonobetaine into L(-)-carnitine by contacting a solution of crotonobetaine or crotonobetaine derivatives with carnitinehydrolyase in the presence of the effector.
    Type: Grant
    Filed: October 25, 1988
    Date of Patent: March 6, 1990
    Assignee: Sigma Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Heinrich Jung, Kirsten Jung, Hans-Peter Kleber
  • Patent number: 4408740
    Abstract: To ensure that a body will be independent of gravitation for the performance of tests, an evacuable protection box is provided which encloses contact free the body from all sides.The protection box has contactless scanning units to monitor the position of the body in its inside. It is conducted along three axes by a guiding system firmly connected to the spacecraft.The movements along each of the three axes is accomplished by driving means controlled by the scanning units so that the protection box follows changed positions of the body relative to the spacecraft.
    Type: Grant
    Filed: June 17, 1981
    Date of Patent: October 11, 1983
    Assignee: Deutsche Forschungs- und Versuchsanstalt fur Luft
    Inventor: Peter Kleber